Melanotic neuro-ectodermal tumour of infancy

Prabir Kumar Jash1, Collin Roy, Kabita Chatterjee

  • 1Department of Plastic Surgery, NRS Medical College and Hospital, Kolkata 700014.

Insights

A rare melanotic neuro-ectodermal tumor of infancy (dihydroxy-phenylalanine) presented as a large oral swelling in a 5-month-old. Surgical removal led to an uneventful recovery, with elevated vanillyl mandelic acid levels normalizing post-operation.

Area of Science:

  • Pediatric Oncology
  • Oral Pathology
  • Developmental Biology

Background:

  • Melanotic neuro-ectodermal tumor of infancy (MNTI) is a rare, benign, but locally aggressive neoplasm.
  • Typically presents in the first year of life, often involving the maxilla or mandible.
  • Early diagnosis and prompt intervention are crucial for optimal outcomes.

Observation:

  • A 5-month-old infant presented with a rapidly enlarging oral mass that significantly obstructed the oral cavity.
  • Clinical presentation suggested a rapidly growing tumor requiring urgent evaluation.
  • Elevated urinary vanillyl mandelic acid (VMA) levels were detected, a marker associated with neuroblastoma and other neural crest tumors.

Findings:

  • The mass was surgically excised in its entirety.
  • Histopathological examination confirmed the diagnosis of melanotic neuro-ectodermal tumor of infancy.
  • Post-operative VMA levels returned to normal, indicating successful tumor removal.

Implications:

  • This case highlights the importance of considering MNTI in infants with rapidly growing oral masses.
  • Prompt surgical management is effective in achieving complete remission.
  • Monitoring urinary VMA levels can aid in diagnosis and post-operative assessment of MNTI.